top of page

Coalition for Compounding Excellence

A Fresh, Affordable Pathway to Compliance and Quality For the Compounding Pharmacy Industry

The ONLY Risk-Based Auditing and Accreditation Model in Compounding

Experienced Auditors > Commitment to Excellence > Far Lower Cost

Blog

Compounding World News

News articles of interest to Compounders and Compounding Pharmacy Owners

FDA moves to exclude three GLP-1s from 503B compounding

FDA moves to exclude three GLP-1s from 503B compounding

Compounding World News

May 71 min read

Wegoy and Ozempic packaged GLP-1 medications

Wegoy and Ozempic packaged GLP-1 medications

US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs

News Article from Reuters: US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs

Compounding World News

May 60 min read

Statement from the Alliance for Pharmacy Compounding on FDA Proposed Rule Regarding 503B Bulks List

Statement from the Alliance for Pharmacy Compounding on FDA Proposed Rule Regarding 503B Bulks List

Compounding World News

Apr 301 min read

FDA Law Blog

FDA Law Blog

FDA’s Pep(tide) Rally! What Compounders and Industry Need to Know (Post 2 of 2)April 22, 2026By Charles D. Snow & Karla L. Palmer —

FDA’s Pep(tide) Rally! What Compounders and Industry Need to Know (Post 2 of 2)

Compounding World News

Apr 223 min read

bottom of page